Language
English
Publication Date
3-1-2024
Journal
Nature Microbiology
DOI
10.1038/s41564-024-01617-w
PMID
38429422
PMCID
PMC11196888
PubMedCentral® Posted Date
9-1-2024
PubMedCentral® Full Text Version
Author MSS
Abstract
Microbial transformation of bile acids affects intestinal immune homoeostasis but its impact on inflammatory pathologies remains largely unknown. Using a mouse model of graft-versus-host disease (GVHD), we found that T cell-driven inflammation decreased the abundance of microbiome-encoded bile salt hydrolase (BSH) genes and reduced the levels of unconjugated and microbe-derived bile acids. Several microbe-derived bile acids attenuated farnesoid X receptor (FXR) activation, suggesting that loss of these metabolites during inflammation may increase FXR activity and exacerbate the course of disease. Indeed, mortality increased with pharmacological activation of FXR and decreased with its genetic ablation in donor T cells during mouse GVHD. Furthermore, patients with GVHD after allogeneic hematopoietic cell transplantation showed similar loss of BSH and the associated reduction in unconjugated and microbe-derived bile acids. In addition, the FXR antagonist ursodeoxycholic acid reduced the proliferation of human T cells and was associated with a lower risk of GVHD-related mortality in patients. We propose that dysbiosis and loss of microbe-derived bile acids during inflammation may be an important mechanism to amplify T cell-mediated diseases.
Keywords
Humans, T-Lymphocytes, Intestines, Inflammation, Graft vs Host Disease, Bile Acids and Salts
Published Open-Access
yes
Recommended Citation
Lindner, Sarah; Miltiadous, Oriana; Ramos, Ruben J F; et al., "Altered Microbial Bile Acid Metabolism Exacerbates T Cell-Driven Inflammation During Graft-Versus-Host Disease" (2024). Faculty, Staff and Students Publications. 8883.
https://digitalcommons.library.tmc.edu/baylor_docs/8883